What hurdles in delivering new modalities, like biologics, are you seeing? Delivery is really the key. We know, if we conduct experiments in the laboratory on cells, we can get incredible results. We ...
ElevateBio, a technology-driven advanced therapy CDMO and gene editing services partner, today announced data from presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual ...
From CAR T to radiopharmaceuticals, we are generating new drug discovery modalities faster than you can say “deoxyribonucleic acid”. At this pace of innovation, even relatively recent advances, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results